Common mechanisms include secondary EGFR mutations, such as T790M, bypass receptor tyrosine kinase activation, such as through MET amplification, or tumour reprogramming through epithelial–mesenchymal transition or transformation to small cell lung cancer. The gene discussed is EGFR; the disease is neoplasm.